Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Verbeken

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2023
Magistral Phage Preparations: Is This the Model for Everyone?Jean-Paul Pirnay, Gilbert Verbeken
Current Opinion in Virology|November 21, 2021
European regulatory aspects of phage therapy: magistral phage preparationsGilbert Verbeken, Jean-Paul Pirnay
Targeted Oncology|January 18, 2012
Biosimilars and market access: a question of comparability and costs?Steven Simoens, Gilbert Verbeken, Isabelle Huys
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Daniel De Vos, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Hilde Van Raemdonck, et al.
Future Microbiology|October 12, 2007
European regulatory conundrum of phage therapyGilbert Verbeken, Daniel De Vos, Mario Vaneechoutte, et al.
Archivum Immunologiae Et Therapiae Experimentalis|February 7, 2014
Call for a dedicated European legal framework for bacteriophage therapyGilbert Verbeken, Jean-Paul Pirnay, Rob Lavigne, et al.
Viruses|February 9, 2018
The Magistral PhageJean-Paul Pirnay, Gilbert Verbeken, Pieter-Jan Ceyssens, et al.
Plos One|July 12, 2013
Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)Maia Merabishvili, Chris Vervaet, Jean-Paul Pirnay, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 25, 2012
Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicineGilbert Verbeken, Jean-Paul Pirnay, Daniel De Vos, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2023
Magistral Phage Preparations: Is This the Model for Everyone?Jean-Paul Pirnay, Gilbert Verbeken
Current Opinion in Virology|November 21, 2021
European regulatory aspects of phage therapy: magistral phage preparationsGilbert Verbeken, Jean-Paul Pirnay
Targeted Oncology|January 18, 2012
Biosimilars and market access: a question of comparability and costs?Steven Simoens, Gilbert Verbeken, Isabelle Huys
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2023
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Daniel De Vos, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
Bacteriophage Production in Compliance with Regulatory RequirementsJean-Paul Pirnay, Maia Merabishvili, Hilde Van Raemdonck, et al.
Future Microbiology|October 12, 2007
European regulatory conundrum of phage therapyGilbert Verbeken, Daniel De Vos, Mario Vaneechoutte, et al.
Archivum Immunologiae Et Therapiae Experimentalis|February 7, 2014
Call for a dedicated European legal framework for bacteriophage therapyGilbert Verbeken, Jean-Paul Pirnay, Rob Lavigne, et al.
Viruses|February 9, 2018
The Magistral PhageJean-Paul Pirnay, Gilbert Verbeken, Pieter-Jan Ceyssens, et al.
Plos One|July 12, 2013
Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)Maia Merabishvili, Chris Vervaet, Jean-Paul Pirnay, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 25, 2012
Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicineGilbert Verbeken, Jean-Paul Pirnay, Daniel De Vos, et al.
Pageof 4